I am a retired computer scientist (HP) and am enjoying researching new medical treatments and the associated companies. I believe that carefully understanding and researching the underlying science will help understand the chance for success of clinical trials (side effects and key factors like delivery for mRNA).
I am a financial adviser and Registered Investment Adviser specializing in emerging growth stocks. I am also a market technician with an article written in the Wall Street Journal about one of my market hedging techniques (Google: Moving The Market-Tracking The Numbers, Edward Levi, The Wall Street Journal). I've spent 11 years at Dean Witter, 18 at Smith Barney, and 8 at Morgan Stanley. I've decided to join Beverly Hills Wealth Management so that I can concentrate on building private hedge fund portfolios for clients, whether related to growth or income, or both.
I specialize in emerging growth investments that run the gamut from medical devices and therapies, technology, and alternative energy.
I've spent a lifetime of research in the technical aspects of the market, measuring market sentiment, momentum, and chart patterns. For many years I've given market presentations to financial advisers at Smith Barney and Morgan Stanley showing extremes in sentiment and chart patterns. I have my own proprietary indicators that measure extremes and hedge clients portfolios at times when protection is in order. My goal is to be fully invested in the rising trends but very protective of portfolios when sentiment and momentum indicators reach extremes. I'm usually early in predicting trends but usually right. Extreme sentiment is a leading indicator, and I believe it precludes market and economic fundamentals as a source of knowledge of changing trends.
Expert Consultant in biotechnology, intellectual property, patents, molecular genetics, genomics, gene regulation, RNA silencing, RNA interference, epigenetics
Editor in Chief, Frontiers in Plant Genetics and Genomics
Professor Emeritus at University of Arizona, School of Plant Sciences, College of Agricultural and Life Sciences, Tucson, Arizona
Individual Investor, regular guy who is trying to better myself and be of service to anyone who seeks my help. Been a proud member of the Recovering community for eight years. I seek to learn and grow in my personal and professional life. Reside north of Chicago.
I'm the author of six published books, an investor, and a cancer survivor. I got my start thirty-two years ago ghost-writing for a UCLA econ. prof who owned a popular stock-picking newsletter. I have been extensively involved in clinical research (consulted with various medical colleges on new technologies) as well as a speaker in post-doctoral continuing ed in the US, UK, and Canada. Right now, I'm re-editing books for publication and writing articles on Seeking Alpha for others who (like me) enjoy doing extensive investment research and profiting from it.
private investor....former student in bio tech ....interested in advancing practical and economical sources of treatment for human welfare with dignity an awareness . methodical research can be done with new technology with a much more efficient an timely manner...especially vaccines developed thru research more than a decade ago....Why an Who is creating the lengthy timeline to get these cancer vaccines to patients....We can send discover satellites to another solar system an RETRIEVE the DATA ! WE as a generation are mapping our entire solar system an beyond...OUR government has a duty to protect its citizens not only by man/made laws, but the very law of NATURE demands accountability from its leaders....I am saddened by their methods.!
Personal investor learning more about the markets everyday. I am looking for more resources to become better informed on a more timely basis on the stocks in my portfolio. Because I am relatively new to being an "active" investor I rely heavily on Seeking Alpha contributors and also on the "comments" from other members. I have learned to dig deeper on authors to see if they have their own agenda they are touting versus trying to help others build shareholder wealth.
Investment background: Private investor focused on income and biotech stocks. Over 30 years experience investing is stocks, options, and bonds. I design my own structured products to maximize income while limiting risks.
Education: BS, MS in Engineering
Awards: 10+patents in disk drives and healthcare devices
Interests: Investing, writing, golf, good food, good wines
A qualified Chartered Certified Accountant and a lover of classical music, my other great passion in life is the trading of shares. Always on the look out for under the radar stocks with great potential, I tend to focus on biotech companies but consider all potential hidden gems.